Showing 1 - 10 of 35,968
Outpatient parenteral antibacterial therapy (OPAT) is an increasingly popular means of containing the costs of antibacterial therapy, by avoiding the need for hospitalisation or allowing early discharge from hospital, in patients with serious infections. It also offers increased comfort and...
Persistent link: https://www.econbiz.de/10004990310
combination of antibacterials or a single broad spectrum agent to offer extensive antibacterial coverage of both Gram-positive and …
Persistent link: https://www.econbiz.de/10004990335
The treatment and prevention of tuberculosis have gained importance as the number of cases continues to increase worldwide and the ability of the disease to pass from one area to another becomes progressively greater. Interventions used in the US to help control the disease include the...
Persistent link: https://www.econbiz.de/10005448913
At least 95% of patients with duodenal ulcers and 80% of patients with gastric ulcers are infected with Helicobacter pylori. H. pylori is clearly recognised as the major culprit involved in the pathophysiology of peptic ulcer disease. Since eradication of this organism has prevented ulcer...
Persistent link: https://www.econbiz.de/10005448927
antibacterials are well tolerated, severe reactions do occur and can add significantly to the cost of care. Among hospitalised … the cost of new antibacterials, a simple comparison of acquisition costs may not accurately reflect the true costs of …
Persistent link: https://www.econbiz.de/10005449000
Adverse drug events occur frequently and lead to a significant number of fatalities each year. It has been estimated that fatalities directly attributable to adverse drug reactions are the fourth to sixth leading cause of death in US hospitals, exceeding deaths caused by pneumonia and diabetes....
Persistent link: https://www.econbiz.de/10005449050
blockers, diltiazem, verapamil and nicardipine; and the macrolide antibacterials, erythromycin and related compounds. Although …
Persistent link: https://www.econbiz.de/10005449102
Cefotaxime is a parenterally administered third generation cephalosporin with a broad spectrum of antimicrobial activity. After more than a decade of use, cefotaxime continues to play an important role in the treatment of patients with serious infections, particularly those caused by...
Persistent link: https://www.econbiz.de/10005449105
In the absence of evidence in the literature on cost factors in the management of leprosy, a reference is made to the sporadic attempts to study costs of case detection and treatment. Such studies indicate that in the currently declining phase of leprosy endemicity, employing a conventionally...
Persistent link: https://www.econbiz.de/10005404853
Meropenem is a carbapenem antibiotic which is active against the majority of aerobic and anaerobic bacteria implicated in serious infections. Its therapeutic efficacy in a wide range of serious infections is similar to that of imipenem/cilastatin and standard combination drug regimens. Hence,...
Persistent link: https://www.econbiz.de/10005590296